Why the study?
Does colchicine improve outcomes and act as a steroid-sparing agent in patients with SLE pericarditis?
Does colchicine improve outcomes and act as a steroid-sparing agent in patients with SLE pericarditis?
Colchicine shows preliminary safety and efficacy as a steroid-sparing treatment for SLE pericarditis in a small case series.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for colchicine as steroid-sparing in SLE pericarditis; controlled trials required before practice change.
Colchicine may be safe and effective in treating SLE pericarditis and used as a steroids-sparing agent. These preliminary results need to be confirmed in a larger study with longer follow-up.
No takes yet. Share an insight, caveat, or question.
Morel et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: